Evaluated by: David B. Kaminsky, M.D., FIAC, January 25, 2018
Original release date: March 8, 2018
Access to this course expires on: January 25, 2021, at 11:59 PM Pacific Time
Clinical and imaging advances in the management of patients with liver disease have significantly altered the scope of disorders encountered by pathologists, shifting biopsy assessment of fibrosis stage among patients with chronic viral hepatitis or steatosis to unraveling complicated medical issues, hepatic effects of polypharmacy/targeted therapies or tumors of unclear etiology. This course prepares pathologists to evaluate these situations in contemporary practice.
Practicing academic and community pathologists, and pathologists-in-training
Upon completion of this educational activity, learners will be able to:
Continuing Medical Education and Continuing Certification
The United States and Canadian Academy of Pathology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The United States and Canadian Academy of Pathology designates this enduring material for a maximum of 12.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
USCAP is approved by the American Board of Pathology (ABPath) to offer Self-Assessment credits (SAMs) and Lifelong Learning (Part II) credit for the purpose of meeting the ABPath requirements for Continuing Certification (CC). Registrants must take and pass the post-test in order to claim SAMs credit. Physicians can earn a maximum of 12 SAM/Part II credit hours.
The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to USCAP and to learners any relevant financial relationship(s) of the individual or spouse/partner that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the CME content. USCAP has reviewed all disclosures and resolved or managed all identified conflicts of interest, as applicable.
The following faculty reported no relevant financial relationships: John A. Hart, M.D., Rish K. Pai, M.D., Ph.D., Rhonda K. Yantiss, M.D., Lisa Yerian, M.D.
The following IM Coordinator who planned and reviewed content for this activity reported no relevant financial relationships: Rhonda K. Yantiss, MD
USCAP staff associated with the development of content for this activity reported no relevant financial relationships.
To earn CME and SAM credit, all learners must take a content-based exam and achieve a minimum score of 80%. If learners do not achieve a passing score of 80%, they have the option to retake the exam. After you pass the test and complete the evaluation, your certificate of completion will be available to view and print by clicking here.
Buy the entire Liver Pathology Can Be Fun -- Really course and get a great discount!
Not A Member? Click Here .